Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury (Q84649317)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

author name string

Clark D Russell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

Jonathan E Millar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

language of work or name

English

0 references

publication date

February 2020

0 references

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

volume

395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

page(s)

473-475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

issue

10223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

SARS: systematic review of treatment effects

27 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients

5

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study.

6

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy

1 reference

12 December 2020

Factors of avascular necrosis of femoral head and osteoporosis in SARS patients' convalescence

1 reference

12 December 2020

The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Use of corticosteroids in treating infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome

1 reference

12 December 2020

Middle East Respiratory Syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Lung pathology of fatal severe acute respiratory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Acute respiratory distress in adults

0 references

Pharmacological agents for adults with acute respiratory distress syndrome

1 reference

12 December 2020

Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Hemodynamic impact of a positive end-expiratory pressure setting in acute respiratory distress syndrome: importance of the volume status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930317-2

7 January 2021

10.1016/S0140-6736(20)30317-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

27 May 2020

COVIDWHO ID

covidwho-523

0 references

1124654674

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json

27 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32043983%20AND%20SRC:MED&resulttype=core&format=json